OVERVIEW

Core Competency Module 2: Evaluation of Chemotherapy Orders and Initial Patient Assessment is organized by Hematology/Oncology Pharmacy Association (HOPA).

End Date: 05-26-2023

Course Description: 
This module provides hematology/oncology pharmacists with comprehensive guidance on verifying an entire chemotherapy order. The module begins with an overview of existing standards on best practices for the safe use of chemotherapy and biological agents and is followed by a discussion on key pieces to extract while reviewing patient charts. Critical components of a chemotherapy order are also discussed at length. Arpita S. Gandhi PharmD, BCOP also reviews tertiary resources to quickly validate chemotherapy regimens, appropriate use of anti-emetics and other pre-medications, reviewing necessary pre-chemotherapy labs, sequence of chemotherapy administration, appropriate use of growth factors, and appropriate prescribing of home medications. Upon completion of this module, participants will be able to quickly navigate through a chemotherapy order and validate the regimen in addition to related supportive care orders seamlessly.

Learning Objectives:
• Discuss standardized medication processes to minimize errors with chemotherapy  
• Review the required components of a chemotherapy order 
• Formulate a systematic method for assessing a chemotherapy order 

Additional details will be posted as soon as information is available.

Credits
  • 0.75 CE Hours
  • TARGET AUDIENCE

    Physician

    SPECIALITIES

    Oncology

    RELATED ONLINE COURSES

    May 25, 2022 - Nov 30, 2026 | Webcast

    State required course for Connecticut ...
    5 AMA PRA Category 1 Credits™
    ...
    More actions
    US$180

    Aug 23, 2022 - Nov 30, 2026 | Webcast

    State required course for New Jersey
    3 AMA PRA Category 1 Credits™
    ...
    More actions
    US$15.20

    Aug 23, 2022 - Nov 30, 2026 | Webcast

    State required course for New Jersey
    3 AMA PRA Category 1 Credits™
    ...
    More actions
    US$102